Congress Park Capital’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.7M Buy
2,268,249
+232,632
+11% +$482K 1.54% 22
2025
Q1
$4.48M Sell
2,035,617
-419,878
-17% -$924K 1.7% 18
2024
Q4
$3.76M Buy
2,455,495
+477,417
+24% +$730K 1.36% 23
2024
Q3
$3.94M Buy
1,978,078
+399,577
+25% +$795K 1.46% 21
2024
Q2
$5.52M Sell
1,578,501
-66,284
-4% -$232K 2.22% 13
2024
Q1
$4.56M Sell
1,644,785
-153,865
-9% -$426K 2.02% 14
2023
Q4
$3.06M Buy
1,798,650
+1,209,500
+205% +$2.06M 1.49% 19
2023
Q3
$607K Buy
589,150
+77,900
+15% +$80.2K 0.32% 68
2023
Q2
$593K Buy
511,250
+190,590
+59% +$221K 0.3% 73
2023
Q1
$484K Buy
320,660
+60,550
+23% +$91.4K 0.25% 75
2022
Q4
$650K Buy
260,110
+89,350
+52% +$223K 0.38% 62
2022
Q3
$721K Buy
170,760
+10,500
+7% +$44.3K 0.42% 51
2022
Q2
$447K Buy
160,260
+32,512
+25% +$90.7K 0.27% 80
2022
Q1
$731K Buy
127,748
+38,131
+43% +$218K 0.37% 62
2021
Q4
$818K Sell
89,617
-30,110
-25% -$275K 0.4% 58
2021
Q3
$1.28M Sell
119,727
-76,760
-39% -$821K 0.65% 44
2021
Q2
$3.05M Buy
196,487
+3,840
+2% +$59.6K 1.53% 16
2021
Q1
$3.12M Sell
192,647
-4,970
-3% -$80.6K 1.75% 15
2020
Q4
$4.18M Sell
197,617
-7,232
-4% -$153K 2.48% 13
2020
Q3
$3.04M Buy
204,849
+4,485
+2% +$66.5K 1.88% 16
2020
Q2
$2.95M Buy
200,364
+89,319
+80% +$1.31M 2.26% 15
2020
Q1
$1.3M Sell
111,045
-2,200
-2% -$25.8K 1.18% 22
2019
Q4
$2.66M Buy
113,245
+1,980
+2% +$46.5K 1.96% 18
2019
Q3
$2.06M Buy
111,265
+1,600
+1% +$29.6K 1.73% 19
2019
Q2
$1.95M Buy
109,665
+58,790
+116% +$1.04M 1.54% 18
2019
Q1
$1.24M Buy
50,875
+4,300
+9% +$105K 1.07% 30
2018
Q4
$1.21M Buy
46,575
+11,350
+32% +$294K 1.33% 24
2018
Q3
$1.12M Sell
35,225
-100
-0.3% -$3.17K 1% 31
2018
Q2
$1.37M Sell
35,325
-3,900
-10% -$151K 1.32% 23
2018
Q1
$1.08M Sell
39,225
-7,400
-16% -$204K 1.11% 27
2017
Q4
$844K Buy
+46,625
New +$844K 0.85% 40